Related Experiment Video
Updated: May 19, 2026

14:20
Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
16.8K
2-Hydroxyoleic Acid as a Self-Assembly Inducer for Anti-Cancer Drug-Centered Nanoparticles
Antonia I Antoniou1, Giulia Nordio2, Maria Luisa Di Paolo3
1Dipartimento di Chimica, Università degli Studi di Milano, Via Golgi 19, 20133 Milano, Italy.
Pharmaceuticals (Basel, Switzerland)
|May 27, 2023
Summary
Novel nanoparticles were created using 2-hydroxyoleic acid and anticancer drugs. These nanoassemblies show significant antitumor activity and enhanced cell penetration, offering a promising new approach to cancer therapy.
Area of Science:
- Drug delivery systems
- Nanotechnology
- Cancer research
Background:
- 2-hydroxyoleic acid (2OHOA) is a potent, nontoxic antitumor drug utilized in membrane lipid therapy.
- 2OHOA's capacity to self-assemble into nanoparticles (NPs) in aqueous environments makes it a suitable candidate for drug delivery.
- Developing effective drug delivery systems is crucial for enhancing anticancer efficacy and minimizing systemic toxicity.
Purpose of the Study:
- To synthesize and characterize novel nanoparticle formulations for cancer therapy.
- To evaluate the antiproliferative activity of these nanoassemblies against various human tumor cell lines.
- To investigate the role of a disulfide-containing linker in drug release and cellular effects.
Main Methods:
- Conjugation of 2-hydroxyoleic acid with anticancer drugs via a disulfide linker to form nanoparticles.
- Antiproliferative assays using human tumor cell lines: biphasic mesothelioma (MSTO-211H), colorectal adenocarcinoma (HT-29), and glioblastoma (LN-229).
- Assessment of intracellular reactive oxygen species (ROS) levels and evaluation of antioxidant effects.
Main Results:
- Synthesized nanoassemblies (16-22a,bNPs) demonstrated significant antiproliferative activity at micromolar and submicromolar concentrations.
- The disulfide linker facilitated enhanced cell penetration and intracellular drug release for most nanoformulations.
- Nanoformulation 17bNP induced intracellular ROS increase in glioblastoma cells, comparable to the free drug, and this effect was mitigated by an antioxidant.
Conclusions:
- The developed nanoparticle formulations show promise as effective drug delivery systems for cancer therapy.
- The self-assembly of 2-hydroxyoleic acid provides a viable platform for creating targeted and efficient anticancer nanomedicines.
- The disulfide linker plays a critical role in the cellular uptake and mechanism of action of the encapsulated drugs.
Keywords:
2-hydroxyoleic acid (2OHOA)anticancer drugsbiphasic mesothelioma (MSTO-211H)colorectal adenocarcinoma (HT-29)conjugatesglioblastoma (LN-229)methyl 2-hydroxyoleatenanoassemblies
